title: In vitro modulating effect of human very-low-density lipoproteins on human polymorphonuclear leukocyte oxidative metabolism and migration.
abstract: In this work, the in vitro effects of very-low-density lipoproteins (VLDL) on human polymorphonuclear leukocyte (PMN) oxidative metabolism and migration were studied. VLDL stimulated PMN superoxide generation in absence of other stimulating agents. The effect of VLDL from normotriglyceridemic subjects was more marked than with VLDL from hypertriglyceridemic subjects. VLDL reduced in a dose-dependent manner the luminol-dependent chemiluminescence of PMN stimulated by phorbol myristate acetate (PMA) and, to a lesser degree, by opsonized zymosan. This effect was observed with VLDL concentrations found in healthy and hypertriglyceridemic patients. Superoxide anion generation was also reduced by preincubation of PMN with VLDL before stimulation with PMA but not opsonized zymosan. VLDL were not cytotoxic for PMN. The above effects appear to be an intrinsic property of VLDL and might lead to reduced PMN-mediated non-specific host defences in hypertriglyceridemic subjects.
authors.affiliation: Laboratoire de Biochimie A, CNRS URA 595, Hôpital Cochin, Paris, France.
authors.forename: N
authors.initials: N
authors.lastname: Idohou
authors.forename: R
authors.initials: R
authors.lastname: Couderc
authors.forename: M
authors.initials: M
authors.lastname: Roch-Arveiller
authors.forename: C
authors.initials: C
authors.lastname: Bonneau
authors.forename: J P
authors.initials: JP
authors.lastname: Giroud
authors.forename: D
authors.initials: D
authors.lastname: Raichvarg
mesh_terms: D002465:Cell Movement / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D008079:Lipoproteins, VLDL / Q000494:pharmacology*; D008081:Liposomes / Q000494:pharmacology; D008163:Luminescent Measurements; D009504:Neutrophils / Q000187:drug effects* / Q000378:metabolism; D010084:Oxidation-Reduction; D013481:Superoxides / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D015054:Zymosan / Q000494:pharmacology
chemical_list: D008079:Lipoproteins, VLDL; D008081:Liposomes; D013481:Superoxides; D015054:Zymosan; D013755:Tetradecanoylphorbol Acetate